|
**URGENT REMINDER** Pre-Market Alert:
Good Morning Trader,
This is an urgent reminder on CIHN, start your research immediately!
For anyone that may have missed my email from earlier, I've included a copy of our alert below.
-------------------------------------------------------------------------------
CIHN Is On HIGH ALERT!
Dear Fellow Trader,
Coming off our latest big winners we couldn't be more excited to keep the momentum going into our newest announcement.
My New Breakout Play Is:
Caribbean International Holdings (CIHN)
CIHN Is On Immediate ALERT!
Symbol: CIHN
Co. Name: Caribbean International Holdings
Website: www.regenerativebioscience.com
About Caribbean International Holdings
Caribbean International Holdings, Inc. is a holding company for Regenerative Bio Science, Inc. ("RBSI"). The Company subsidiary RBSI is focused on helping individuals protect and ensure their future quality of life through Adult Stem Cell Incubation and the practice of regenerative medicine in the United States and the Dominican Republic. RBSI's mission is not only to allow patients to store their Stem Cells for future use, but also perform patient funded stem cell therapies for degenerative diseases such as MS, Arthritis, Degenerative Heart Diseases, Diabetes and a host of experimental therapies in the brain trauma disease sector including CTE. The goal is to become a global leader in establishing protocols that can be patented and utilized to heal patients around the world.
Adult stem cells work as the repairmen of the body by replenishing and regenerating damaged tissues and cells. Certain conditions have shown marked improvement when treated with adult stem cells taken from the patient's own body. Regenerative BioScience is a revolution in healthcare using a patient's own adult stem cells.
CIHN has recently entered into stem cell market that is projected to be a 6.6 Billion Dollar industry by 2016. CIHN has appointed Dr. Leonel Liriano as its medical Director.
CIHN appears to be catching the attention of investors and could be setting up for some impressive growth potential! If you have not started your research on CIHN I would suggest you do so now. You can start by reading my full report below and please continue to do your independent research.
The highly anticipated play that we've been waiting for is the very exotic CIHN!
CIHN announced in March that it has decided to focus its effort in the area of Regenerative and Personalized Medicine by providing Adult Stem Cell Incubation and Storage to individuals looking for the potential to protect and ensure their future quality of life.
The company finalized operational agreements that allow CIHN to extract Adult Stem Cells from patients in close proximity to where they live through a network of approved doctors nationwide.
Stem Cell Research Is HUGE Business!!
The market is currently estimated to be $3.2 Billion!
By 2016 analysts project stem cell research and related products will hit $6.6 Billion!
And those numbers are just in the U.S.
Globally Stem Cell research is expected to surpass the $46 Billion mark by 2017! KaBOOM!!!!
If These Kinds of Numbers Don't Get YOU Excited I Don't Know What Would!
These stem cells will be stored and available for use as future opportunities arise. Currently there are over 100 diseases and conditions identified worldwide for the use of Adult Stem Cells derived from fat to heal the body.
CIHN has also been working on international Stem Cell services in Dominican Republic to supplement the US operations.
What makes CIHN so seriously hot right now is news that was recently released that CIHN Retires 70 Million Shares Which Reduced Outstanding Shares By Approximately 17%; Company To Focus Solely On Its Stem Cell Activities.
We have appended a portion of CIHN's exciting news below.
Caribbean International Holdings (CIHN) Retires 70 Million Shares Which Reduced Outstanding Shares By Approximately 17%; Company To Focus Solely On Its Stem Cell Activities
On August 1, 2013 The Company issued 75,000,000 million shares as part of a venture to open restaurants in association with South Of The Border Holdings, Inc.; 70 Million have been canceled and returned to the company treasury.
To view CIHN's recent news in its entirety, please use this link ---> http://finance.yahoo.com/news/caribbean-international-holdings-cihn-retires-110000032.html
INVESTOR HIGHLIGHTS
- CIHN believes the focus of the Company offers the greatest opportunity to shareholders and the health and well-being of all those interested in exploring this exciting new breakthrough.
- Stem cell research is a promising area of biotechnology, which holds tremendous potential in rendering investor profits.
- CIHN is trading around $.007 and has been experiencing what looks like a bullish trend in the chart over the past week.
- CIHN is involved in an industry that is valued over $3.2B and by 2016 analysts projects it will hit $6.6 billion... Globally Stem Cell research is expected to surpass the $46 billion mark by 2017!
- Major factors driving growth in the market include increasing investments from Governments worldwide. The US currently represents the largest regional market worldwide.
- The recent news and the future of CIHN could generate a lot of buzz through the investment community!
Without our report you could miss out on information that you could possibly use. But please, still continue to do your research as well and put CIHN on your radar for Thursday!
I recommend starting your own research on CIHN right away. This could be a Huge Stock Play! Remember we are coming off of picks like JZHG that ran up 300%, HHWW that ran up 147%, BLBK that ran up 50% from open, CLTS that ran up 100% from open!
And I almost forgot we alerted members on MRHD July 7th and it absolutely exploded out of the gates rallying to a new 52 week high of $1.01 representing a whopping 910% Gain from the open and an earth shattering 38,746% Gain from previous close!
So move quickly on CIHN to enjoy the rewards! Now let's grab some serious gains!
Once again our team has dug deep to uncover this potential monster! Those who are smart and fast enough will be able to grab cheap shares and reap the rewards!! Pull up CIHN fast! GO, GO, GO!!!
As always we encourage all of our subscribers to complete their own due diligence and visit the company website: www.regenerativebioscience.com
Happy Trading!!
The OTCtipReporter Team
DONT MISS ANOTHER HOT OPPORTUNITY TO MAKE
HUGE PROFITS!
Help Spread the word about OTCtipReporter!
You can call us toll free at: 1-800-850-9305
Offices are open Monday through Friday, 9:30 am to 4:00 pm EST
Email: office@OTCtipReporter.com
www.OTCtipReporter.com
Investor Awareness and IR Services
If you are interested in our Investor Awareness and IR Services
Contact us at 1-800-850-9305 or email us at office@OTCtipReporter.com
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
The companies that are discussed on OTCtipReporter have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company's actual _results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to _buy or sell securities. OTCtipReporter is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before _purchasing or selling any securities viewed on OTCtipReporter or mentioned herein. Affiliates, officers, directors and employees of OTCtipReporter may have also _b o u g h t or may _b u y shares of companies mentioned herein and may profit in the event those shares rise in value. OTCtipReporter wi ll not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to _b u y, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not _liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any _purchase or sale decision be discussed with a financial adviser or broker prior to completing any such _purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in _private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to _b u y or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains "forward looking" statements within the meaning of _Section-27(a) of the U.S. Securities_ _Act-of-1933_ and _Section _21(e) of t he U.S. _Securities _Exchange _Act-of -934. Neither OTCtipReporter, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to _purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may _result in investors losing all of their invested capital. Past performance does not _guarantee future results. The information contained herein contains "forward-looking _statements," within the meaning of _Section-27A_ of the Securities Act-of-1933 and Section_ _21E of the Securities Exchange _Act-of-1934. Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense _competition, lack of meaningful research _results, inadequate capital, termination of contracts or agreements, adv erse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein. More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.
Buying_ and Selling of Shares
OTCtipReporter intends to sell its shares. OTCtipReporter may sell its shares for less than target prices given in opinions. OTCtipReporter affiliates, officers, directors and employees may have also _b o u g h t or may _b u y the shares discussed in this report and may profit in the event those shares rise in value. OTCtipReporter will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before _purchasing or selling any securities viewed on OTCtipReporter. If at any time you wish to be removed from our list simply unsubscribe in any of the previous emails sent to you.
17(B) DISCLAIMER
OTCtipReporter is owned and operated by LionsGate Ventures Inc.. LionsGate Ventures Inc. and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as "OTC" or "we" or "us" or "our). OTC electronically disseminates information (the "Information") on its website, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Profiled Companies' (the "Issuer" or "Issuers" or "Profiled Company" or "Profiled Companies"), the securities of which are most frequently common stock shares quoted on the Over the Counter Bulletin Board ("OTCBB") or _Pink Sheets. The Information is based on information received from Issuers, publicly available information, such as quarterly (with unaudited financial statements) and annual reports (with audited financial statement s) filed with the Securities and Exchange Commission ("SEC"), quarterly and annual unaudited financial reports and Information and Disclosure Statements filed with the _Pink Sheets, the Issuer's website and information obtained through search engines such as Yahoo Finance, Market Watch and Business Wire. We synthesize the Information from these informational sources for our Readers as a starting point for further inquiry into the Issuer and its securities. Because OTC receives compensation for OTC's dissemination of the Information (as disclosed in our Compensation Disclosure Section), including at times in the form of common stock shares (the "Shares"), OTC should not be considered to be an independent provider of the Information. OTC is not a research analyst, registered investment advisor or registered securities broker dealer and the Information should not be construed in any manner, shape or form as investment-advice, investment recommendations or opinions or viewpoints regarding the Profiled Company or its securities or as a solicitation to offer, _purchase or sell the Profiled Company's securities. OTC does not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information and conducts no due diligence whatso ever of the Profiled Companies. Because the Information is presented on an "as is" basis, your use of the Information is at your own risk. OTC disclaims, expressly and impliedly, all warranties of any kind, including whether the Information is accurate or reliable or _free of errors. By reading the Information, the Reader hereby agrees to indemnify and hold OTC harmless from any _liability for any claimed direct, indirect, incidental, punitive, or consequential damages pertaining to the Information. Statements contained in the Information that are not historical facts are forward looking statements that involve risks and uncertainties as indicated by words such as "believes", "expects", "estimates", "may", "will" or "should" or "anticipates" or similar expressions. These forward looking statements may materially differ from the Issuer's actual operational and financial _results or its actual achieve ments, claimed or otherwise. OTC does not undertake any responsibility whatsoever of these forward looking statements, nor any legal obligation whatsoever of updating the Information. The Information is presented only as a brief "snapshot" of the Profiled Company and should only be used, at most, and if at all, as a starting point for Readers to conduct a thorough investigation of the Profiled Company and its securities, to consult with their financial, _legal or other advisor(s) and avail themselves of filings and information that may be accessed at sec . g o v or _pink sheets or other electronic medium, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the _Pink Sheets; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (e) consulting investment guides at sec . g o v and finra . c o m pertaining to the risks of investing in penny stocks. In the end _result, Readers must evaluate and bear all the risks associated with the Information, including reliance on its accuracy, completeness or usefulness. In all instances, the Reader should conduct further inquiry into the Profiled Company and its securities. The Profiled Companies are subject to possible risks, including but not limited to: (a) the Information pertains to penny stocks that are subject to the SEC's penny stock rules and commonly involve a high degree of risk that may _result in the loss of some or all of an investment in the Profiled Company's securities; (b) the Issuer's penny stock may be thinly traded, which may lead to difficulties of selling its securities; (c) the SEC reporting issuer may be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports) or the _Pink Sheet quoted company may be delinquent in its _Pink Sheet reporting obligations as indicated by _Pink Sheets New Service's posting a negative "sign" pertaining to the Issuer at _pink sheets, as follows: (i) "Lime or before the Information is being disimited Information" for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the _Pink Sheets; (ii) "_Pink Sheets - No Information", which indicates companies that are unable or unwilling to provide disclosure to the public markets, to the SEC or the _Pink Sheets; and (iii) "Caveat Emptor", signifying "_Buyer Beware" that there is a public interest concern associated with a company's _illegal spam campaign, questionable stock promotion, known investigation of a company's fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions; (d) whether the Issuer is a development stage company with little or no operations, the securities of which should be considered extremely speculative for investment purposes; (e) OTC's selling of an Issuer's securities may cause its stock price to significantly decline, especially when such securities are thinly traded; (f) many companies that have their securities quoted on the OTCBB or _Pink Sheets (as well as even Exchange listed companies) have been negatively affected by the current economic downturn and lack of adequate financing to meet their operational goals or expansion plans; (g) any percentage gain from the previous day close presented on our website at is not and should not be construed as any indication whatsoever of the future stock price of an Issuer's securities or its operational _results; (h) many of the energy related and other Profiled Companies are subject to increasing environmental and other governmental regulations, which subjects them to significant costs and possible fines and liabilities for failure to comply with applicable state and federal statutes; (i) OTC may receive compensation in shares of the Issuer and it or its associates, affiliated entities, officers, directors or immediate family members may sell the Shares immediately upon their receipt as well as during the dissemination of such Information or within hours, days, weeks or months thereafter, or at any time; as a _result, OTC's selling activities may cause significant volatility in the Issuer's stock price and/or significantly depress the Issuer's stock price; (j) OTC may _buy and sell the Shares in the open market before, during or after the dissemination of the Information or at any time, which may cause significant volatility including drops in the price of the Issuer's stock price and/or significantly depress the Issuer's stock price; (k) future success of many OTCBB and _Pink Sheet quoted Issuers is dependent upon receiving adequate financing or raising sufficient capital, which they may be unable to obtain; (l) there is an inherent and actual conflict of interest that exists between our Readers' interests and OTC's interests because OTC's owners, OTC: (i) receive the Shares as compensation for disseminating the Information and thereafter sell those Shares at any time for monetary gain, including at the same time the Information is being disseminated or shortly thereafter or at any time; and (ii) buys and sells the Profiled Company's shares in the open market at the same tseminated or shortly after the dissemination of the Information or at any time; (m) we do not receive any direct verification from the Issuer regarding the Information; (n) a third _party shareholder may have a potential or actual conflict of interest in paying OTC for the dissemination of the publication while still holding the Issuer's shares of common stock that he or she may sell after the third _party shareholder has paid OTC with his or her shares; (o) the Information should not be interpreted in any shape, form or m a n n e r whatsoever as an indication of the Issuer's future stock price or future financial performance since, among other reasons, such "comparison" companies are listed on exchanges (i.e., the New York Stock Exchange) and trade at stock prices that are thousands of percent higher than the companies we profile; and (p) Readers may encounter difficulties determining what information contained in our publications is material or non-material making it all the more imperative that they conduct further investigation of the Profiled Company and its securities ; and (q) OTC hires third _party Service Providers to electronically disseminate live news regarding the Issuer, information which we do not independently provide to the Service Provider or verify and upon which we have no control over. We pay _cash consideration to the Service Providers; no securities compensation is paid to the Service Providers; and (r) our employees post messages on their individual message boards as a method of disseminating the Information on behalf of our Issuer clients which should never be used as a means of conducting analysis into the Issuer and should only be used as a starting point to obtain the names of _pink sheet or OTC Bulletin Board. Please be advised that we have been compensated seven thousand five hundred dollars cash_ by a non-affiliated third party to profile CIHN for a one day investor awareness program. WE OWN NO SHARES.
|
